赛托生物：控股子公司药品糠酸氟替卡松获化学原料药欧洲CEP证书

Core Viewpoint - Saito Biopharmaceuticals (赛托生物) announced that its subsidiary, Srey Pharmaceuticals, received the Certificate of Suitability (CEP) from the European Medicines Agency for the active pharmaceutical ingredient fluticasone furoate, indicating its compliance with European pharmacopoeia standards [2] Group 1 - The certified chemical raw material, fluticasone furoate, is a potent glucocorticoid used in nasal sprays for the treatment of seasonal and perennial allergic rhinitis in patients aged 2 years and older [2] - Fluticasone furoate is also utilized in inhalation powder formulations for the treatment of asthma and chronic obstructive pulmonary disease (COPD) [2]